Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Politics : View from the Center and Left -- Ignore unavailable to you. Want to Upgrade?

To: epicure who wrote (239611)	12/9/2013 10:54:06 AM
From: Wharf Rat	Read Replies (1) \| Respond to of 542009

"The Us has basically turned its population in to lab rats-" Make that toddler lab rats. The studies are 3 months long, on subjects with an 18 month life span. I'd like to see 2 or 3 gen studies... maybe 3 years long. let's find out what we're doing to my granddaughters before we do it to my granddaughters. The study 1, published in the peer-reviewed journal Food and Chemical Toxicology, looked for adverse health effects in rats fed NK603 maize (corn), developed by biotech company Monsanto to resist the herbicide glyphosate and approved for animal and human consumption in the European Union, United States and other countries. It reported that the rats developed higher levels of cancers, had larger cancerous tumours and died earlier than controls. The researchers have not conclusively identified a mechanism for the effect. The rats were monitored for two years (almost their whole lifespan), making this the first long-term study of maize containing these specific genes. About a dozen long-term studies of different GM crops have failed to find such stark health effects 2. An earlier test of NK603 maize in rats in a 90-day feeding trial — the current regulatory norm — sponsored by Monsanto showed no adverse effects 3. nature.com